Dr. Philip Moshe and Eran Atlas may be the two most influential people in the diabetes industry in the past two decades. They are the developers of the artificial intelligence algorithms behind Medtronic's artificial pancreas and the world's first endocrine digital expert.
Dr. Phillip Moshe & Eran Atlas
Diabetes Diabetes Diabetes Diabetes patients are faced with a chronic disease that stresses a harsh lifestyle that aggravates . To millions of young and adult patients around the world. It is estimated that 463 million adults currently suffer from diabetes (9.3% of the world's adult population). It is estimated that the total number of people will increase to 578 million (10.2%) by 2030, and to 700 million (10.9%) by 2045.
There are hundreds of technical solutions that claim to help diabetic patients, but statistics show that despite so many diabetes technologies, about 50% of patients worldwide cannot achieve the blood sugar that all diabetic patients should pay attention to every day balance. This figure is shocking.
In addition, the impact of diabetes technology on the well-being of diabetic patients is minimal at best. So far, nothing can replace the care provided after frequent consultations with endocrinologists who are familiar with the patient. However, the harsh reality is that there are hardly enough doctors and related practitioners to cope with the increasing diabetes tsunami sweeping the modern world. In the United States alone, every endocrinologist estimates that 41,000 adult patients need continuous care, at least 4 times per person per year.
Application of new AI technology
Moshe Dr. Philip and Dr. Eran Atlas started researching the "dream artificial intelligence for diabetes" more than ten years ago.To solve this defect. They study an artificial intelligence-driven "pancreatic brain" that will enable patients to continuously and subtly balance insulin control on their own.
has conducted 13 years of clinical research in collaboration with some of the top medical institutions in the United States, the European Union and Israel, and has produced a "logic" that uses real artificial intelligence algorithms to simulate the human pancreas and human endocrinologists Logic and empirical technology.
A miracle happened. Their algorithm is implemented by the global medical equipment giant Medtronic in its artificial pancreatic insulin pump (Minimed 640G). This is the first and only thing in the world that provides continuous blood sugar control for patients. In addition, Dream's algorithms and technology, as a clinical decision support system (CDSS), received the fourth approval from the US FDA, enabling endocrinologists to deal with a significantly increased number of patients with type I and type II diabetes (by orders of magnitude). Their novel digital medical system based on artificial intelligence aims to provide professional endocrine care for millions of patients around the world who currently cannot access such services, thereby revolutionizing the world of diabetes.
Will the doctor be replaced by AI?
The US Food and Drug Administration, the FDA, is very downplaying this, very carefully surrounding these medical advances. They are rightly concerned that medical systems based on artificial intelligence will be seen as "potential substitutes" for human doctors. Nonetheless, Dream's algorithms and technology have been clinically proven in the past decade to provide patients with high-quality endocrine expert advice, because it successfully adds pancreas-like "management" capabilities to artificial insulin pumps.
The scientific and medical work done by Dr. Philip Moshe and Dr. Eran Atlas has and still affects the lives of millions of children and adults.But most importantly, they proved that in the 21st century, when medical standard care can provide online services, humans are no longer restricted by themselves or by biological factors. Although there are so many warnings and disclaimers in the world, we dare to say that Dream's team has successfully established the world's first artificial intelligence-driven "digital endocrinologist" and the world's first to imitate the pancreas personalized Algorithms for insulin management-these two achievements are likely to change the fundamental lifestyle of diabetic patients as we know it.
Tianmu Academy, a better tomorrow!
This article is original by serpant, welcome to pay attention, and bring you a long knowledge!
.
